A review of methylene blue treatment for cardiovascular collapse

Research output: Contribution to journalReview articlepeer-review

Abstract

Background Historically, methylene blue (MB) has been used for multiple purposes, including as an antidote for toxin-induced and hereditary methemoglobinemia, ifosfamide-induced encephalopathy, and ackee fruit and cyanide poisoning; as an aniline dye derivative, antimalarial agent, and antidepressant. Discussion Most recently, the use of MB has been advocated as a potential adjunct in the treatment of shock states. Our article reviews the role of MB in septic shock, anaphylactic shock, and toxin-induced shock. MB is proposed to increase blood pressure in these shock states by interfering with guanylate cyclase activity, and preventing cyclic guanosine monophosphate production and vasodilatation. Summary MB may be an adjunct in the treatment of septic shock, anaphylactic shock, and toxin-induced shock.

Original languageEnglish
Pages (from-to)670-679
Number of pages10
JournalJournal of Emergency Medicine
Volume46
Issue number5
DOIs
StatePublished - May 2014
Externally publishedYes

ASJC Scopus Subject Areas

  • Emergency Medicine

Keywords

  • anaphylactic shock
  • methylene blue
  • septic shock
  • shock due to toxin
  • Shock/drug therapy
  • Enzyme Inhibitors/therapeutic use
  • Humans
  • Anaphylaxis/drug therapy
  • Methylene Blue/therapeutic use
  • Shock, Septic/drug therapy

Cite this